Lenograstim is a recombinant human granulocyte colony-stimulating factor (G-CSF) used to stimulate the production of white blood cells, particularly neutrophils. This medication is often used in the context of cancer treatment to mitigate the side effects of chemotherapy and bone marrow transplantation that can lead to neutropenia, a condition characterized by abnormally low levels of neutrophils.
